Ann: Appendix 4E and 2020 Financial Report, page-8

This is my first time reading through a report like this (new to investing) but from what I can see things still look positive? Considering travel bans should have reduced sales, they are still up...they are also still in the process of researching covid effects and seem to have shown some legit inhibition properties.
They are also looking into the US army for helping with the travelers diarrhea, which a previous report from US said was the main concern for their forces with travel.
They ALSO are conducting two clinical trials next year and looking at getting FDA approval for their new drug.

So from the report, it looks like next year has the potential for them to do extremely well just for travelan sales going up once travel is allowed again (covid news will probably help that) let alone the chance for it to explode with FDA approval, US forces agreement for a drug and positive clinical trials?

Am I right in thinking this? I get people are selling because they might be disappointed the report didn't have any ridiculous new info in it (which from what I've seen about disclosure, couldn't have happened anyway) but the company still seems to be in a really really good position leading into the new year?

All imo and DYOR, just giving my thoughts from what I've read